|
| 37978802 | Molecular mechanism of regulation of RhoA GTPase by phosphorylation of RhoGDI. | Biophys J | 2024 |
| 37978802 | Molecular mechanism of regulation of RhoA GTPase by phosphorylation of RhoGDI. | Biophys J | 2024 |
| 37524384 | Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance. | Annu Rev Pharmacol Toxicol | 2024 |
| 37524384 | Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance. | Annu Rev Pharmacol Toxicol | 2024 |
| 36369657 | Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire. | Protein Sci | 2023 |
| 36369657 | Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire. | Protein Sci | 2023 |
| 37946677 | Spatial Mechano-Signaling Regulation of GTPases through Non-Degradative Ubiquitination. | Adv Sci (Weinh) | 2023 |
| 37935253 | Cancer and Autism: How PTEN Mutations Degrade Function at the Membrane and Isoform Expression in the Human Brain. | J Mol Biol | 2023 |
| 37920394 | Protein conformational ensembles in function: roles and mechanisms. | RSC Chem Biol | 2023 |
| 38085330 | SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities. | Cell Mol Life Sci | 2023 |
| 37790340 | Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2. | bioRxiv | 2023 |
| 37871498 | Cell phenotypes can be predicted from propensities of protein conformations. | Curr Opin Struct Biol | 2023 |
| 36910650 | Pathogen-driven cancers from a structural perspective: Targeting host-pathogen protein-protein interactions. | Front Oncol | 2023 |
| 36907321 | AlphaFold, allosteric, and orthosteric drug discovery: Ways forward. | Drug Discov Today | 2023 |
| 36580595 | Opinion: Protein folds vs. protein folding: Differing questions, different challenges. | Proc Natl Acad Sci U S A | 2023 |
| 36573259 | Activation mechanisms of clinically distinct B-Raf V600E and V600K mutants. | Cancer Commun (Lond) | 2023 |
| 36815703 | Strategy toward Kinase-Selective Drug Discovery. | J Chem Theory Comput | 2023 |
| 36814845 | Graph embedding and Gaussian mixture variational autoencoder network for end-to-end analysis of single-cell RNA sequencing data. | Cell Rep Methods | 2023 |
| 36759615 | Visualizing RNA conformational and architectural heterogeneity in solution. | Nat Commun | 2023 |
| 36808143 | Pan-cancer clinical impact of latent drivers from double mutations. | Commun Biol | 2023 |
| 36747841 | How PTEN mutations degrade function at the membrane and life expectancy of carriers of mutations in the human brain. | bioRxiv | 2023 |
| 37124926 | Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK. | Biophys Rev | 2023 |
| 37433832 | Architectural basis for cylindrical self-assembly governing Plk4-mediated centriole duplication in human cells. | Commun Biol | 2023 |
| 36726377 | Small GTPase Ran: Depicting the nucleotide-specific conformational landscape of the functionally important C-terminus. | Front Mol Biosci | 2023 |
| 37500946 | Author Correction: Architectural basis for cylindrical self-assembly governing Plk4-mediated centriole duplication in human cells. | Commun Biol | 2023 |
| 38085330 | SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities. | Cell Mol Life Sci | 2023 |
| 37920394 | Protein conformational ensembles in function: roles and mechanisms. | RSC Chem Biol | 2023 |
| 37946677 | Spatial Mechano-Signaling Regulation of GTPases through Non-Degradative Ubiquitination. | Adv Sci (Weinh) | 2023 |
| 37790340 | Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2. | bioRxiv | 2023 |
| 37935253 | Cancer and Autism: How PTEN Mutations Degrade Function at the Membrane and Isoform Expression in the Human Brain. | J Mol Biol | 2023 |
| 37500946 | Author Correction: Architectural basis for cylindrical self-assembly governing Plk4-mediated centriole duplication in human cells. | Commun Biol | 2023 |
| 37871498 | Cell phenotypes can be predicted from propensities of protein conformations. | Curr Opin Struct Biol | 2023 |
| 37124926 | Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK. | Biophys Rev | 2023 |
| 37433832 | Architectural basis for cylindrical self-assembly governing Plk4-mediated centriole duplication in human cells. | Commun Biol | 2023 |
| 36815703 | Strategy toward Kinase-Selective Drug Discovery. | J Chem Theory Comput | 2023 |
| 36814845 | Graph embedding and Gaussian mixture variational autoencoder network for end-to-end analysis of single-cell RNA sequencing data. | Cell Rep Methods | 2023 |
| 36747841 | How PTEN mutations degrade function at the membrane and life expectancy of carriers of mutations in the human brain. | bioRxiv | 2023 |
| 36580595 | Opinion: Protein folds vs. protein folding: Differing questions, different challenges. | Proc Natl Acad Sci U S A | 2023 |
| 36808143 | Pan-cancer clinical impact of latent drivers from double mutations. | Commun Biol | 2023 |
| 36910650 | Pathogen-driven cancers from a structural perspective: Targeting host-pathogen protein-protein interactions. | Front Oncol | 2023 |
| 36907321 | AlphaFold, allosteric, and orthosteric drug discovery: Ways forward. | Drug Discov Today | 2023 |
| 36573259 | Activation mechanisms of clinically distinct B-Raf V600E and V600K mutants. | Cancer Commun (Lond) | 2023 |
| 36759615 | Visualizing RNA conformational and architectural heterogeneity in solution. | Nat Commun | 2023 |
| 36726377 | Small GTPase Ran: Depicting the nucleotide-specific conformational landscape of the functionally important C-terminus. | Front Mol Biosci | 2023 |
| 34628220 | Interpretable artificial intelligence and exascale molecular dynamics simulations to reveal kinetics: Applications to Alzheimer's disease. | Curr Opin Struct Biol | 2022 |
| 35712080 | Neurodevelopmental disorders, immunity, and cancer are connected. | iScience | 2022 |
| 36306797 | Deep generative molecular design reshapes drug discovery. | Cell Rep Med | 2022 |
| 35651316 | The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia. | Biophys J | 2022 |
| 35508574 | The mechanism of activation of MEK1 by B-Raf and KSR1. | Cell Mol Life Sci | 2022 |
| 36154343 | How has artificial intelligence impacted COVID-19 drug repurposing and what lessons have we learned? | Expert Opin Drug Discov | 2022 |